Dyne Therapeutics, Inc. · NASDAQ:DYN
Atlas Venture Fund XI, L.P. reported a 4.00% stake in Dyne Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 13, 2025
Atlas Venture Fund XI, L.P. reported a 4.00% stake in Dyne Therapeutics, Inc., 5,697,508 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).
- Stake
- 4.00%
- Shares
- 5,697,508
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Atlas Venture Fund XI, L.P. | 4.00% | 5,697,508 |
| Atlas Venture Associates XI, L.P. | 4.00% | 5,713,470 |
| Atlas Venture Associates XI, LLC | 4.00% | 5,713,470 |
| Atlas Venture Opportunity Fund I, L.P. | 1.00% | 1,458,568 |
| Atlas Venture Associates Opportunity I, L.P. | 1.00% | 1,458,568 |
| Atlas Venture Associates Opportunity I, LLC | 1.00% | 1,458,568 |
| Atlas Venture Opportunity Fund II, L.P. | 1.40% | 1,958,427 |
| Atlas Venture Associates Opportunity II, LP | 1.40% | 1,958,427 |
| Atlas Venture Associates Opportunity II, LLC | 1.40% | 1,958,427 |
Source
Related
- Dyne Therapeutics, Inc.
- Atlas Venture Fund XI, L.P.
- Dyne Therapeutics, Inc. shareholders
- Schedule 13G/A · Atlas Venture Fund XI, L.P. · Aug 13, 2026
- Form 4 · Kerr Douglas · Oct 22, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026